Protocol Page


	Study ID (Protocol Number)
	CA180-330


	STUDY LOCATIONS*
	Advanced Oncology New York, NY 10013 Recruiting	Alamance Regional Cancer Center Burlington, NC 27215 Active, not recruiting
	Akron General Medical Center Akron, OH 44302 Recruiting	Arizona Oncology Associates, PC - HAL Phoenix, AZ 85016 Active, not recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
	STUDY OVERVIEW
	The purpose of this study is to better understand the use of tyrosine kinase inhibitors (TKI) in patients newly diagnosed with CML and their quality of life in a real-world setting.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.